优化培养条件和裂解方法提高hRANKL在大肠杆菌内的表达（英文）

RANKL/RANK/OPG轴在骨代谢过程中起到中心调节作用,也是近年来骨相关疾病治疗研究的热点之一。RANKL蛋白在RANKL/RANK/OPG轴信号传递过程中起到关键作用,在骨代谢相关实验研究中用途广泛。但是,使用大肠杆菌Escherichia coli可溶表达重组人源RANKL蛋白(hRANKL)时产量远低于鼠源RANKL(mRANKL)。本研究通过将LB培养基pH值调整并稳定在7.5、降低诱导表达温度至16℃并优化细菌裂解条件,成功地将可溶hRANKL产量增加到了对照组的5-12倍。该方法有效提高了hRANKL在大肠杆菌中可溶表达的产量,同时也是研究重组蛋白在大肠杆菌内的可溶表达策略的有益尝试。     

Barnase在大肠杆菌中的分泌表达和诱导条件优化

从解淀粉芽孢杆菌中PCR分别扩增解淀粉芽孢杆菌核糖核酸酶barnase基因及其抑制剂barstar基因,采用将barnase基因置于barstar基因保护下的克隆策略,以pET-22b（＋）质粒为基础,构建大肠杆菌分泌型表达质粒．IPTG诱导表达目的蛋白后将培养基蛋白进行SDS-PAGE分析并从诱导温度、IPTG诱导浓度和诱导时间三方面初步优化诱导表达条件．     

基因重组大肠杆菌表达血红素加氧酶-1及培养条件优化

【背景】血红素加氧酶-1 (HO-1)具有抗氧化应激、抗凋亡和抗纤维化等多种生理效应,有望成为一种新型药物应用于临床疾病的治疗。【目的】构建表达HO-1的基因重组大肠杆菌(Escherichiacoli),并优化其表达培养条件,实现HO-1高产率的表达。【方法】PCR法克隆集胞藻(Synechocystissp.)PCC6803的HO-1基因(ho1),构建重组质粒pET-28a-ho1,转化大肠杆菌BL21(DE3)菌株,单因素实验优化表达培养基的种类、诱导剂添加时间、诱导培养时间、诱导剂浓度和诱导培养温度。【结果】构建了表达HO-1的基因重组大肠杆菌BL21(DE3)/pET-28a-ho1菌株,用甘油(GY)培养基培养至菌体浓度OD_(600)约为0.8时,加入终浓度为0.1 mmol/L的IPTG诱导,30°C诱导培养6 h,HO-1的表达量最高,Ni-NTA柱分离纯化得到的HO-1收率占细胞总蛋白的10.9%。【结论】获得了可溶性表达HO-1的基因重组大肠杆菌及其较佳的培养条件,为进一步研究集胞藻来源的HO-1的酶学性质和应用奠定了基础。     

多表位恶性疟疾疫苗M.RCAg-1在大肠杆菌表达的条件优化和大规模培养

通过以培养基配方、IPTG浓度、金属离子复合液浓度、镁离子浓度、表达时间、接种量、诱导时间点等发酵的重要条件对重组蛋白表达量影响的研究,确定多表位恶性疟疾疫苗M.RCAg-1蛋白最佳表达条件为以改良TB培养基培养、最优Mg2+,诱导剂IPTG和金属离子复合液浓度分别为10mmol/L,0.5mmol/L,6μl/ml,接种量为10%,表达时间为4.5h,将优化后的参数用于50L发酵罐进行连续3批中试规模的发酵,最终收获菌体湿重平均为31.8±1.78g/L,目的蛋白表达量可占菌体总蛋白的50%左右,试验确定了恶性疟疾多表位随机组合蛋白M.RCAg-1在大肠杆菌中的最优表达条件,该条件能够适合大规模培养需要。     

外源蛋白在大肠杆菌中的表达定位策略

外源基因在大肠杆菌中表达是对基因重组技术的成功应用。外源基因在不同的大肠杆菌表达系统中表达产物可能定位于大肠杆菌空间结构的不同位置：胞质,胞质膜,胞周质,胞外膜和胞外培养基,五种表达定位方式各有其特点和途径。     

外源基因在大肠杆菌中表达研究进展

近年来,基因工程技术的迅速发展,大量有价值的蛋白质大肠杆菌中获得了高表达。多种表达系统的完善与发展,及蛋白质分离纯化技术的提高,异源蛋白的产量与纯度已不再是困扰人们的主要问题,人们开始更多地关注异源蛋白的活性,比活性及异源蛋白的正确性,完整性。随着这些问题的解决,重组蛋白的应用才能真正走向成熟。     

人epiregulin在大肠杆菌中的表达

利用ＲＴ－ＰＣＲ的方法首次从人肺癌细胞Ａ５４９中扩增得到了ｅｐｉｒｅｇｕｌｉｎ的ｃＤＮＡ。在３’端添加６个组氨酸密码子后将期 克隆到本实验室构建的大肠杆菌高效碱性磷酸酶分泌表达系统中进行分泌表达。表达产物经Ｎｉ柱一步分离后得到纯化。对其进行氨基酸序列分析,结果与报道的人ｅｐｉｒｅｇｕｌｉｎ的序列一致。ＭＴＴ法测定其对Ｂａｌｂ／ｃ３Ｔ３细胞有很强的促增殖作用,而对表皮癌细胞Ａ４３１有较强的抑制生长作     

GABAA受体蛋白片段在大肠杆菌细胞表达条件研究

为了提高GABAA受体α1蛋白片段在大肠杆菌中表达量,研究了重组菌的发酵条件,包括培养基,接种量,温度,摇床转速,pH,诱导培养时间和诱导剂IPTG使用浓度等对GABAA受体蛋白片段表达的影响。结果表明重组菌以LB培养基为发酵基质,按3%接种量,37℃培养细胞3.5h后IPTG32℃诱导5h,菌体生物量为3.25g/L,目标蛋白表达量达95mg/L。用16L发酵罐进行放大培养,菌体生物量达4.95g/L,发酵周期5.5h。最高目标蛋白表达量达到136mg/L。     

大肠杆菌副产物合成途径删除提高外源蛋白表达水平

大肠杆菌是应用最广泛的外源基因表达宿主。为探索阻断副产物产生途径对提高大肠杆菌表达外源蛋白的能力,本实验以野生型大肠杆菌菌株为基础,删除其乳酸脱氢酶基因(ldhA),磷酸烯醇式丙酮酸合成酶基因(pps)和丙酮酸甲酸裂解酶基因(pflB)。在此基础上,以甘露聚糖酶基因man为报告基因,考察阻断以上代谢途径对大肠杆菌产酶能力的影响。结果显示,以上述三个基因叠加删除的三重突变株为宿主时,重组茵产酶水平最高,比酶活达到158.3 U/mg,相比野生出发菌株提高82.3%。     

重组大肠杆菌生产可溶性MBP融合肝素酶的培养条件优化

为确立肝素酶Ⅰ的高效生产工艺,利用麦芽糖结合蛋白(MBP)与肝素酶Ⅰ融合性能,通过构建相应的表达质粒pMHS,在大肠杆菌方面实现了肝素酶Ⅰ可溶性表达。通过对LB培养基摇瓶培养E.coliTB1(pMHS)的诱导时机、诱导剂用量以及添加葡萄糖、酵母提取物、乙醇、氯霉素和卡那霉素等一系列培养条件的优化,确定了该可溶性肝素酶融合蛋白MBP-hepA的最佳生产条件。     

重组大肠杆菌生产谷胱甘肽发酵条件的研究

研究了重组Ｅ．Ｃｏｌｉ产ＧＳＨ的发酵条件,重点考察了添加酵母膏、前体氨基酸和ＡＴＰ的影响。结果发现,前体氨基酸和ＡＴＰ均能促进胞内ＧＳＨ的积累,若在发酵０ｈ和１２ｈ分别加入２０ｇ／ＬＡＴＰ和９ｍｍｏｌ／Ｌ前体氨基酸,则细胞干重和胞内ＧＳＨ含量可分别比对照提高２４％和１４倍。应用正交试验得出的针对细胞干重和ＧＳＨ总量的最佳组合,最大细胞干重和ＧＳＨ总量比原试验中的最好结果分别提高了１０％和２６％。在分析了该菌对葡萄糖利用情况的基础上,对该菌进行了指数流加培养,２５ｈ细胞干重与发酵液内ＧＳＨ总量分别达到８０ｇ／Ｌ和８８０ｍｇ／Ｌ,比摇瓶最好结果分别提高了８３和４６倍。     

提高大肠杆菌通过MVA途径合成异戊二烯

异戊二烯是橡胶合成的重要前体物质。为了提高菌株的异戊二烯产量,本实验室在研究中构建了一株异戊二烯产气的菌株BW-01,基于蛋白质预算理论的指导,理性设计通过改变质粒拷贝数、增加稀有密码子等合成生物学手段调控关键限速酶编码基因表达,从而提高大肠杆菌外源MVA代谢途径的异戊二烯产量。摇瓶发酵实验中我们构建的新产气菌株BW-07比原有的产气菌株BW-01的产量提高了73%,达到了761.1 mg/L。为后续菌株改造及进行发酵罐实验奠定了基础。     

Improved glutathione production by gene expression in Escherichia coli

AIMS: To improve glutathione (GSH) production in Escherichia coli by different genetic constructions containing GSH genes. METHODS AND RESULTS: GSH production was very low in E. coli by the expression of gshI gene. An increase of GSH production was achieved by the expression of both gshI and gshII genes in E. coli. A higher GSH production, namely 34.8 mg g(-1) wet cell weight, was obtained by simultaneous expression of two copies of gshI gene and one copy of gshII gene. CONCLUSIONS: The simultaneous expression of two copies of gshI gene and one copy of gshII gene resulted in a significant increase in GSH production. SIGNIFICANCE AND IMPACT OF THE STUDY: The expression strategy for GSH production described here can be used to increase gene expression and obtain high production rates in other multienzyme reaction systems.     

重组蛋白在大肠杆菌周间腔的分泌表达

大肠杆菌是用于生产重组蛋白的重要工程宿主菌。但是,要获得足够的正确折叠的蛋白还存在一定的缺陷,其中一种解决此问题的方法就是使重组蛋白分泌到大肠杆菌的周间腔里。在这篇综述中,主要讨论了使重组蛋白分泌表达至大肠杆菌周间腔的近期的研究进展。     

Succinate production from sucrose by metabolic engineered Escherichia coli strains under aerobic conditions

Two metabolically engineered E. coli strains HL2765k and HL27659k, while capable of producing succinate from glucose with high yields, are not able to grow and produce succinate on sucrose. Consequently, the pUR400 plasmid containing scrK, Y, A, B, and R genes was introduced into HL2765k and HL27659k, respectively. Shake flask culture studies showed that the resulting strains can utilize sucrose; the strain HL2765k pUR400 and HL27659k pUR400 can produce succinate aerobically with a molar yield of 0.78 ± 0.02 mol/mol and 1.35 ± 0.13 mol/mol, respectively. On introduction of the plasmid pHL413, which encodes the heterologous pyruvate carboxylase (PYC) from Lactococcus lactis, the molar succinate yield increased to 1.60 ± 0.01 mol of succinate per mole of sucrose by the HL2765k pUR400 pHL413 strain and to 1.84 ± 0.10 by the HL27659k pUR400 pHL413 strain. In aerobic batch bioreactor studies, the succinate production rate was faster, and succinate production reached 101.83 mM with a yield of 1.90 when dissolved oxygen (DO) was controlled at 40 ± 7%. In addition, the results showed that DO had an important effect on succinate production by influencing PYC activity. This work demonstrates the possibility of producing succinate aerobically using sucrose as the carbon source.     

原核系统可溶性表达策略

获得大量目的蛋白的最简单最经济的方法是利用原核表达系统表达外源基因.但由于原核系统的自身特点,使所表达的蛋白常常形成无活性的包涵体.多年来世界各国的研究为解决这一问题尝试了多种方法.本简单介绍原核表达系统的特点及提高蛋白可溶性表达的常用方法.     

A method of enhancing verocytotoxin production by Escherichia coli

The number of verocytotoxin producing Escherichia coli (VTEC) present in the faeces during an infection may be very low, making their detection difficult. We report a method for enhancing toxin production by VTEC using mitomycin C as an inducing agent with the aim of improving the detection of VTEC. In pure culture, mitomycin C enhanced toxin production up to 100-fold. When applied to mixed faecal culture, toxin could be detected in mitomycin C treated samples when standard cultures were negative and when substantially fewer verocytotoxin-producing bacteria were present. Use of this method may aid in the detection of VTEC and is appropriate for use in the routine diagnostic laboratory.     

Practical protocols for production of very high yields of recombinant proteins using Escherichia coli

The gram‐negative bacterium Escherichia coli offers a mean for rapid, high yield, and economical production of recombinant proteins. However, high‐level production of functional eukaryotic proteins in E. coli may not be a routine matter, sometimes it is quite challenging. Techniques to optimize heterologous protein overproduction in E. coli have been explored for host strain selection, plasmid copy numbers, promoter selection, mRNA stability, and codon usage, significantly enhancing the yields of the foreign eukaryotic proteins. We have been working on optimizations of bacterial expression conditions and media with a focus on achieving very high cell density for high‐level production of eukaryotic proteins. Two high‐cell‐density bacterial expression methods have been explored, including an autoinduction introduced by Studier (Protein Expr Purif 2005;41:207–234) recently and a high‐cell‐density IPTG‐induction method described in this study, to achieve a cell‐density OD₆₀₀ of 10–20 in the normal laboratory setting using a regular incubator shaker. Several practical protocols have been implemented with these high‐cell‐density expression methods to ensure a very high yield of recombinant protein production. With our methods and protocols, we routinely obtain 14–25 mg of NMR triple‐labeled proteins and 17–34 mg of unlabeled proteins from a 50‐mL cell culture for all seven proteins we tested. Such a high protein yield used the same DNA constructs, bacterial strains, and a regular incubator shaker and no fermentor is necessary. More importantly, these methods allow us to consistently obtain such a high yield of recombinant proteins using E. coli expression.     

Rapid protein release from Escherichia coli by chemical permeabilization under fermentation conditions

Overall protein release greater than 75% in less than 1 h can be attained by exposing exponentially growing Escherichia coli cells to 0.4 M guanidine plus 0.5% Triton X-100 at 37 degrees C in medium. Cell growth stops immediately upon addition of the chemicals, but the cells are not lysed. Guanidine concentrations lower than 0.2 M, in conjunction with 0.5% Triton X-100, do not release significant intracellular protein, nor do they inhibit cell growth. Under these conditions, the cells undergo an adaptation that confers resistance to protein release by further treatment with guanidine and Triton X-100. Cells treated with 0.2 M guanidine plus 0.5% Triton X-100 display intermediate behavior. Protein release is approximately 35%, and growth is temporarily interrupted by an extended lag phase. Subsequent resumption of cell growth results in resistant cells and no additional protein release. This resistance is shown to be reversible and is most likely due to physiological adaptation rather than genetic mutation.